Register today for this one-day meeting bringing together top executives and clinical researchers from both the EU and US advanced therapies communities to foster discussion aimed at furthering the field as a whole. Join large pharma leaders, experts in translational medicine and top company executives for this unique, exclusive meeting. 

Save the date - March 25, 2015 - for ARM's 3rd Annual Regen Med Investor Day! Don't miss the only financing event organized specifically for the advanced therapies sector providing institutional, strategic and venture investors with a unique opportunity to gain insight into the top regen med and advanced therapies companies.

Didn't make it to San Francisco for ARM's 5th Annual Regen Med & Advanced Therapies State of the Industry Briefing? ARM's Industry Update PPT presentation can now be downloaded and webcasts of the two panels are available to view!

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more